Literature DB >> 23964191

Primary bilateral small lymphocytic lymphoma of ocular adnexal origin: Imprint cytology suggests the intraoperative diagnosis.

Arghya Bandyopadhyay1, Kaushik Majumdar, Mimi Gangopadhyay, Kalyan Khan, Subrata Chakraborty, Asim Kr Ghosh.   

Abstract

Ocular adnexal lymphomas (OAL) involve the peri-global soft tissues like orbit, eyelid, conjunctiva, lacrimal gland. We describe a rare case of primary bilateral OAL, histomorphologically small lymphocytic lymphoma, B cell phenotype of lacrimal gland origin. Rapid intraoperative diagnosis can be suggested on imprint cytology; subsequent histology and immunohistochemistry are helpful for confirmation and further line of management. Since no preformed lymphoid structures are expected within the orbit or lacrimal gland, any lymphoid mass here should be critically evaluated as a lymphoproliferative lesion.

Entities:  

Keywords:  B cell; Bilateral; Imprint cytology; Lacrimal; Lymphoma; Ocular adnexal

Year:  2012        PMID: 23964191      PMCID: PMC3729853          DOI: 10.1016/j.sjopt.2012.03.006

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  7 in total

Review 1.  Primary orbital lymphoma.

Authors:  Christopher M Nutting; Christopher D Jenkins; Andrew J Norton; Ian Cree; Geoffrey E Rose; P Nicholas Plowman
Journal:  Hematol J       Date:  2002

2.  Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options.

Authors:  Didier Decaudin; Patricia de Cremoux; Anne Vincent-Salomon; Remi Dendale; Livia Lumbroso-Le Rouic
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

3.  Fine needle aspiration cytology diagnosis of lymphoid lesions of the orbit.

Authors:  Dilip K Das
Journal:  Acta Cytol       Date:  2007 May-Jun       Impact factor: 2.319

4.  Malignant tumors of the orbit. Analysis of the Florida Cancer Registry.

Authors:  C E Margo; Z D Mulla
Journal:  Ophthalmology       Date:  1998-01       Impact factor: 12.079

5.  Outcome and prognostic factors in ocular adnexal lymphoma.

Authors:  Marin Nola; Adrian Lukenda; Magdolna Bollmann; Miro Kalauz; Marko Petrovecki; Reinhard Bollmann
Journal:  Croat Med J       Date:  2004-06       Impact factor: 1.351

6.  Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.

Authors:  B Esmaeli; P McLaughlin; B Pro; F Samaniego; I Gayed; F Hagemeister; J Romaguera; F Cabanillas; S S Neelapu; R Banay; L Fayad; M Wayne Saville; L W Kwak
Journal:  Ann Oncol       Date:  2009-01-15       Impact factor: 32.976

Review 7.  Orbital lymphoma: role of radiation.

Authors:  B S Yadav; S C Sharma
Journal:  Indian J Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.848

  7 in total
  1 in total

1.  Conjunctival follicular lymphoma after treatment for invasive squamous cell carcinoma.

Authors:  Laura Pires da Cunha; Jeison Nadai Barros; Marcia Motono; Felipe D'Almeida Costa; Marcelo Carvalho da Cunha; Martha Motono Chojniak
Journal:  Case Rep Ophthalmol       Date:  2014-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.